Takeda gets key U.S. regulatory approval to buy Shire

Takeda gets key U.S. regulatory approval to buy Shire


Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc .



from Biotech News